HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

about

Diabetic Nephropathy: a Tangled Web to Unweave.Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.circHIPK2-mediated σ-1R promotes endoplasmic reticulum stress in human pulmonary fibroblasts exposed to silica.

P2860

Q41993558-ED5F8681-5AF0-4D48-A7D4-77EBF5D13DE6 Q47249032-0AD5640D-827B-45D7-936A-BD0407868C87 Q47295982-0E465F9A-DAD0-480F-8B09-3CB7C38AC56F

P2860

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

Item

http://www.wikidata.org/entity/Q26996407

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@ast

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@en

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@nl

type

Item

label

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@ast

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@en

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@nl

prefLabel

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@ast

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@en

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@nl

P1476

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

@en

P2093

John Cijiang He

http://www.w3.org/2001/XMLSchema#string

Melinda M Nugent

http://www.w3.org/2001/XMLSchema#string

P2860

Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors

Role of transforming growth factor beta in human disease

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

Antifibrotic activities of pirfenidone in animal models

NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses

Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons

Transcriptional control by the TGF-beta/Smad signaling system

Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria

A collective form of cell death requires homeodomain interacting protein kinase.

P304

132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2015.00132

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kyung Lee

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276126188

http://www.w3.org/2001/XMLSchema#string

P698

25972814

http://www.w3.org/2001/XMLSchema#string

P932

4411988

http://www.w3.org/2001/XMLSchema#string

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

about

P2860

P2860

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932